<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3172">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04403009</url>
  </required_header>
  <id_info>
    <org_study_id>YLS2020(112)</org_study_id>
    <nct_id>NCT04403009</nct_id>
  </id_info>
  <brief_title>The Clinical Difference Between the Nonfatal Patients and the Fatal Patients With Severe COVID-19</brief_title>
  <official_title>The Clinical Difference Between the Nonfatal Coronavirus Disease 2019 (COVID-19) Patients and the Fatal Cases With Severe COVID-19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The First Affiliated Hospital of Guangzhou Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The First Affiliated Hospital of Guangzhou Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate the difference of the difference between the nonfatal Coronavirus Disease 2019
      (COVID-19) Patients and the fatal Patients .The cross sectional study was undertaken to
      compare the clinical information (laboratory and radiologic characteristics)of nonfatal
      participants and fatal cases. The investigators wish figure out the clinical character of the
      fatal participants. The result may help the physician to find the fatal patients with
      COVID-19 more easily. The fatal patients with COVID-19 could be treated early.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2020</start_date>
  <completion_date type="Anticipated">June 20, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 6, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Lymphocyte cell</measure>
    <time_frame>2 month</time_frame>
    <description>the counting of Lymphocyte(counts/L)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>d-dimer</measure>
    <time_frame>2 month</time_frame>
    <description>d-dimer（mg/L）</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PLT</measure>
    <time_frame>2 month</time_frame>
    <description>the counting of Platelets（(counts/L)）</description>
  </primary_outcome>
  <primary_outcome>
    <measure>CRP</measure>
    <time_frame>2 month</time_frame>
    <description>the level of C-reactive protein (mg/uL)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>LDH</measure>
    <time_frame>2 month</time_frame>
    <description>lactate dehydrogenase ( U/L)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>CK</measure>
    <time_frame>2 month</time_frame>
    <description>creatine kinase (U/L)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PT</measure>
    <time_frame>2 month</time_frame>
    <description>prothrombin time(second)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ALT</measure>
    <time_frame>2 month</time_frame>
    <description>alanine aminotransferase(U/L)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>AST</measure>
    <time_frame>2 month</time_frame>
    <description>aspartate aminotransferase(U/L)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>NK cell</measure>
    <time_frame>2 month</time_frame>
    <description>natural killer cell(counts/L)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PCT</measure>
    <time_frame>2 month</time_frame>
    <description>procalcitonin（ng/ml）</description>
  </primary_outcome>
  <primary_outcome>
    <measure>IL-6</measure>
    <time_frame>2 month</time_frame>
    <description>interleukin-6(mg/L)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the clinical difference of radiologic characteristics between the fatal patients with COVID -19 and the non fatal cases</measure>
    <time_frame>2 months</time_frame>
    <description>CT scan feature</description>
  </secondary_outcome>
  <other_outcome>
    <measure>SPO2</measure>
    <time_frame>2 month</time_frame>
    <description>oxygen Saturation</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Coronavirus Disease 2019</condition>
  <condition>Character of the Severe Patients</condition>
  <arm_group>
    <arm_group_label>the nonsevere Coronavirus Disease 2019 Patients</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>the severe Coronavirus Disease 2019 Patients</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>no intervention</intervention_name>
    <description>no intervention</description>
    <arm_group_label>the nonsevere Coronavirus Disease 2019 Patients</arm_group_label>
    <arm_group_label>the severe Coronavirus Disease 2019 Patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The patients with Coronavirus Disease 2019
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patients with Coronavirus Disease 2019

          -  Positive result on real-time reverse-transcriptase-polymerase-chain-reaction

          -  Positive result on chest computed tomography

        Exclusion Criteria:

          -  No
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>jianheng zhang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>First Afiliated hospital of Guangzhou medical university</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>jianheng zhang, MD</last_name>
    <phone>13480226298</phone>
    <email>582833253@qq.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Guangzhou Medical University</name>
      <address>
        <city>Guanzhou</city>
        <state>Guangdong</state>
        <zip>520120</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>jianheng zhang, MD</last_name>
      <phone>13480226298</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hankou Hospital</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430014</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>jianheng zhang, MD</last_name>
      <phone>13480226298</phone>
      <email>582833253@qq.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>April 21, 2020</study_first_submitted>
  <study_first_submitted_qc>May 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 27, 2020</study_first_posted>
  <last_update_submitted>May 24, 2020</last_update_submitted>
  <last_update_submitted_qc>May 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The First Affiliated Hospital of Guangzhou Medical University</investigator_affiliation>
    <investigator_full_name>Zhang Jianheng</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronavirus Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>It is not decided</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

